Role of ER Stress in the Pathogenesis of Primary Open Angle Glaucoma
内质网应激在原发性开角型青光眼发病机制中的作用
基本信息
- 批准号:8813843
- 负责人:
- 金额:$ 24.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-04-01 至 2017-03-31
- 项目状态:已结题
- 来源:
- 关键词:Advisory CommitteesApoptosisApoptoticAqueous HumorAutophagocytosisAutopsyCell DeathCellsChronicClinicalDataDegradation PathwayDevelopmentDexamethasoneDiagnosisDiseaseEducational process of instructingEndoplasmic ReticulumEyeFailureFunctional disorderGRP78 geneGRP94GeneticGlaucomaHomeostasisHumanIndividualKnockout MiceLaboratoriesLaboratory ResearchLeadLearningLysosomesMentorsModelingMolecular ChaperonesMusMutationNerve DegenerationOcular HypertensionOptic NervePathogenesisPathway interactionsPatientsPhasePhenotypePhenylbutyratesPhosphorylationPhysiologic Intraocular PressurePlayPrimary Open Angle GlaucomaProcessProteinsResearch InstituteResistanceRetinal Ganglion CellsRisk FactorsRoleSirolimusSodium phenylbutyrateSteroidsTestingTissuesTopical applicationTrabecular meshwork structureTrainingTransgenic MiceTransgenic OrganismsWestern Blottingabstractingcareer developmentcommon treatmentendoplasmic reticulum stressexperiencegenetic risk assessmentimprovedinduced pluripotent stem cellinhibitor/antagonistinsightmouse modelmutantmyocilinnovelpreventprotein aggregateprotein degradationprotein misfoldingpublic health relevanceresponsesensorsymposium
项目摘要
Abstract
Primary open angle glaucoma (POAG), the most common form of glaucoma, is usually accompanied by
elevated intraocular pressure (IOP) due to failure of the trabecular meshwork (TM) to maintain normal levels of
aqueous humor outflow. We recently generated a novel transgenic murine model (Tg-MYOCY437H) that
expresses mutant myocilin, a known leading genetic cause of POAG in humans and replicates human
glaucoma phenotypes. Importantly, we have associated endoplasmic reticulum (ER) stress to the
pathogenesis of glaucoma in Tg-MYOCY437H mice. Misfolded myocilin accumulates in the ER, induces ER
stress and activates a protective unfolded protein response (UPR). Along with UPR activation, mutant myocilin
also induces autophagy, a process of lysosomal degradation known to degrade protein aggregates. However,
failure to eliminate myocilin aggregates possibly due to insufficient UPR and impaired autophagy, TM cells
induce the ER stress-initiated apoptotic transcriptional factor, Chop, which may further worsen ER homeostasis
and cause TM dysfunction/loss, elevating IOP and resulting in POAG. The current proposal will further
investigate the role of chronic ER stress in the pathogenesis of myocilin as well as non-myocilin associated
POAG. During the mentored phase, the proposed studies will determine whether failure to activate the
protective UPR (Atf-6¿-/-) exacerbates glaucoma phenotypes, whereas interference with ER stress-induced
apoptosis (Chop-/-) prevents glaucoma in Tg-MYOCY437H mice. In addition, we will investigate whether ER
stress is activated in port-mortem TM tissues from POAG donors. During the independent phase, we will
examine whether induction of ER stress in the TM is associated with elevation of IOP in a mouse model of
dexamethasone-induced ocular hypertension. In addition, we will examine the role of autophagy in degradation
of myocilin aggregates and will determine whether inducing autophagy by rapamycin will rescue the glaucoma
of Tg-MYOCY437H mice. Specifically, the candidate will learn and generate new models of ER stress using
Atf6¿ and Chop knockout mice, generate induced pluripotent stem cells (iPSCs)-derived trabecular meshwork-
like cells from POAG patients, and characterize a dexamethasone-induced ocular hypertension mouse model
in the laboratory of Dr. Val Sheffield. Additionally, during the mentored phase, the candidate will continue his
professional and scientific career development through continual guidance from the advisory committee. He
will attend scientific conferences, and collaborate with ER stress expert, Dr. Thomas Rutkowski and glaucoma
clinical expert, Dr. Lee Alward. He will also acquire teaching experience. This project will facilitate continued
technical, intellectual, and professional training of the candidate, and assist the candidate in the establishment
of an independent research laboratory at an academic research institute.
摘要
原发性开角型青光眼(POAG)是青光眼的最常见形式,通常伴有
由于小梁网(TM)未能维持正常的眼压水平而导致的眼压升高
房水流出。我们最近建立了一种新的转基因小鼠模型(TG-MYOCY437H),该模型
表达突变的myoclin,已知的人类POAG的主要遗传原因,并复制人类
青光眼表型。重要的是,我们将内质网(ER)应激与
TG-MYOCY437H小鼠青光眼发病机制的研究错误折叠的肌球蛋白在内质网中积聚,诱导内质网
应激并激活保护性未折叠蛋白反应(UPR)。在UPR激活的同时,突变的肌球蛋白
还会诱导自噬,这是一种已知的降解蛋白质聚集体的溶酶体降解过程。然而,
未能清除Myocin聚集体可能是由于UPR不足和自噬功能受损,TM细胞
诱导内质网应激启动的细胞凋亡转录因子CHOP,可能进一步恶化内质网稳态
并导致TM功能障碍/丢失,升高眼压,导致POAG。目前的提议将进一步
探讨慢性内质网应激在霉菌素及非霉菌素相关发病机制中的作用
普阿格。在指导阶段,拟议的研究将确定未能激活
保护性UPR(ATF-6-/-)加剧青光眼表型,而干扰内质网应激诱导
细胞凋亡(CHOP-/-)可预防TG-MYOCY437H小鼠的青光眼。此外,我们将调查ER是否
应激在POAG供者的临死TM组织中被激活。在独立阶段,我们将
观察TM中内质网应激的诱导是否与眼压升高有关
地塞米松致高眼压。此外,我们还将研究自噬在退化中的作用。
并将确定雷帕霉素诱导自噬是否能挽救青光眼
Tg-MYOCY437H小鼠。具体地说,应试者将学习并生成新的ER压力模型
ATF6和CHOP基因敲除小鼠,产生诱导多能干细胞(IPSCs)来源的小梁网-
类似POAG患者的细胞,并表征地塞米松诱导的高眼压小鼠模型
在瓦尔·谢菲尔德博士的实验室里。此外,在指导阶段,候选人将继续他的
通过咨询委员会的持续指导,实现职业发展的专业化和科学化。他
将参加科学会议,并与ER应激专家Thomas Rutkowski博士和青光眼合作
临床专家李·阿尔沃德博士。他还将获得教学经验。该项目将促进继续
对应聘者进行技术、智力和专业培训,并协助应聘者建立
一个学术研究机构的独立研究实验室。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gulab Zode其他文献
Gulab Zode的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gulab Zode', 18)}}的其他基金
Development and characterization of an inducible model for myocilin POAG
肌纤蛋白 POAG 诱导模型的开发和表征
- 批准号:
10661911 - 财政年份:2023
- 资助金额:
$ 24.89万 - 项目类别:
Targeting ER Stress Pathway Using Sodium 4-Phenylbutyrate for the Treatment of POAG
使用 4-苯基丁酸钠靶向 ER 应激通路治疗 POAG
- 批准号:
10202609 - 财政年份:2018
- 资助金额:
$ 24.89万 - 项目类别:
Targeting ER Stress Pathway Using Sodium 4-Phenylbutyrate for the Treatment of POAG
使用 4-苯基丁酸钠靶向 ER 应激通路治疗 POAG
- 批准号:
9788452 - 财政年份:2018
- 资助金额:
$ 24.89万 - 项目类别:
Crosstalk Between Unfolded Protein Response and Autophagy for the Treatment of Glaucoma
未折叠蛋白反应与自噬之间的串扰用于治疗青光眼
- 批准号:
9124324 - 财政年份:2016
- 资助金额:
$ 24.89万 - 项目类别:
Crosstalk between chronic ER stress and mitophagy for the treatment of POAG
慢性 ER 应激与线粒体自噬治疗 POAG 之间的串扰
- 批准号:
10850091 - 财政年份:2016
- 资助金额:
$ 24.89万 - 项目类别:
Crosstalk between chronic ER stress and mitophagy for the treatment of POAG
慢性 ER 应激与线粒体自噬治疗 POAG 之间的串扰
- 批准号:
10445174 - 财政年份:2016
- 资助金额:
$ 24.89万 - 项目类别:
Role of ER Stress in the Pathogenesis of Primary Open Angle Glaucoma
内质网应激在原发性开角型青光眼发病机制中的作用
- 批准号:
8822297 - 财政年份:2014
- 资助金额:
$ 24.89万 - 项目类别:
Role of ER Stress in the Pathogenesis of Primary Open Angle Glaucoma
内质网应激在原发性开角型青光眼发病机制中的作用
- 批准号:
9039612 - 财政年份:2014
- 资助金额:
$ 24.89万 - 项目类别:
Role of ER Stress in the Pathogenesis of Primary Open Angle Glaucoma
内质网应激在原发性开角型青光眼发病机制中的作用
- 批准号:
8383990 - 财政年份:2012
- 资助金额:
$ 24.89万 - 项目类别:
Role of ER Stress in the Pathogenesis of Primary Open Angle Glaucoma
内质网应激在原发性开角型青光眼发病机制中的作用
- 批准号:
8534133 - 财政年份:2012
- 资助金额:
$ 24.89万 - 项目类别:
相似国自然基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
- 批准号:LBY21H010001
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
- 批准号:81703335
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
- 批准号:81670594
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
- 批准号:81470791
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
- 批准号:81301123
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
- 批准号:39500043
- 批准年份:1995
- 资助金额:9.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Spatial Restriction of Apoptotic Machinery during Neuronal Apoptosis and Pruning
神经元凋亡和修剪过程中凋亡机制的空间限制
- 批准号:
10596657 - 财政年份:2021
- 资助金额:
$ 24.89万 - 项目类别:
Spatial Restriction of Apoptotic Machinery during Neuronal Apoptosis and Pruning
神经元凋亡和修剪过程中凋亡机制的空间限制
- 批准号:
10417219 - 财政年份:2021
- 资助金额:
$ 24.89万 - 项目类别:
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
- 批准号:
441952-2013 - 财政年份:2015
- 资助金额:
$ 24.89万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
- 批准号:
441952-2013 - 财政年份:2014
- 资助金额:
$ 24.89万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Understanding the activation of pro-apoptotic Bcl-2 family proteins for the development of modulators of apoptosis
了解促凋亡 Bcl-2 家族蛋白的激活以开发凋亡调节剂
- 批准号:
nhmrc : 1059331 - 财政年份:2014
- 资助金额:
$ 24.89万 - 项目类别:
Project Grants
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
- 批准号:
441952-2013 - 财政年份:2013
- 资助金额:
$ 24.89万 - 项目类别:
Postgraduate Scholarships - Doctoral
Apoptotic Osteocytes Promote Chondrocyte Apoptosis via Soluble Factors
凋亡骨细胞通过可溶性因子促进软骨细胞凋亡
- 批准号:
251802 - 财政年份:2012
- 资助金额:
$ 24.89万 - 项目类别:
Studentship Programs
Defining the mechanism(s) by which the cellular inhibitor of apoptosis protein 2 (cIAP2) contributes to early stage atherosclerosis development by directly promoting the participation of key apoptotic pathways within lesion-associated macrophages
确定凋亡蛋白细胞抑制剂 2 (cIAP2) 通过直接促进病变相关巨噬细胞内关键凋亡途径的参与来促进早期动脉粥样硬化发展的机制
- 批准号:
191299 - 财政年份:2009
- 资助金额:
$ 24.89万 - 项目类别:
Operating Grants
ATP release during apoptosis and its relevance to apoptotic cell clearance
凋亡过程中 ATP 释放及其与凋亡细胞清除的相关性
- 批准号:
8075522 - 财政年份:2009
- 资助金额:
$ 24.89万 - 项目类别:
ATP release during apoptosis and its relevance to apoptotic cell clearance
凋亡过程中 ATP 释放及其与凋亡细胞清除的相关性
- 批准号:
7676912 - 财政年份:2009
- 资助金额:
$ 24.89万 - 项目类别: